EDARBI 80 MG — DIN 02381397
AZILSARTAN MEDOXOMIL (AZILSARTAN MEDOXOMIL POTASSIUM) : 80 MG · BAUSCH HEALTH, CANADA INC. · TABLET · wholesale supply in Canada
Health Canada status: MARKETED
What is EDARBI?
EDARBI 80 MG contains AZILSARTAN MEDOXOMIL (AZILSARTAN MEDOXOMIL POTASSIUM) : 80 MG. It is listed in the Health Canada Drug Product Database under DIN 02381397, held by BAUSCH HEALTH, CANADA INC., supplied as TABLET for ORAL administration. Health Canada currently lists it as marketed, status dated 13-Jul-2021. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is EDARBI used for?
EDARBI (azilsartan medoxomil) is an angiotensin II receptor blocker (ARB) indicated for the treatment of mild to moderate essential hypertension. EDARBI may be used alone or concomitantly with thiazide diuretics or calcium channel blockers.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Is there a generic Azilsartan Medoxomil in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
2 holders have a Canadian DIN containing Azilsartan Medoxomil, across 4 DINs, of which 4 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| AURO PHARMA INC | 2 | 2 | AURO-AZILSARTAN MEDOXOMIL | Sourceable in Canada |
| BAUSCH HEALTH, CANADA INC. | 2 | 2 | EDARBI | Sourceable in Canada |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 80 MG |
|---|---|
| Dosage form | TABLET |
| Route | ORAL |
| Pack configuration (monograph) | EDARBI 40 mg tablets are supplied in cartons containing 7 tablets and 2 blisters of 14 tablets each. EDARBI 80 mg tablets are supplied in cartons containing 2 blisters of 14 tablets each. |
| Storage | null |
Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
Substance and classification
| Active substance | Azilsartan Medoxomil |
|---|---|
| ATC code | C09CA09 |
| AHFS class | 24:32.08 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 02381397 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2381397 |
| Brand name | EDARBI |
| Generic / active ingredient | AZILSARTAN MEDOXOMIL (AZILSARTAN MEDOXOMIL POTASSIUM) : 80 MG |
| Market authorization holder | BAUSCH HEALTH, CANADA INC. |
| Health Canada schedule | Prescription |
| ATC code | C09CA09 |
| ATC anatomical main group | C — Cardiovascular system |
| ATC therapeutic subgroup | C09CA |
| Current status | MARKETED |
| Status date | 13-Jul-2021 |
| Original market date | 2012-11-08 00:00:00 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
4 of 4 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| AURO-AZILSARTAN MEDOXOMIL | 40 MG | TABLET | AURO PHARMA INC | MARKETED | 02547015 |
| AURO-AZILSARTAN MEDOXOMIL | 80 MG | TABLET | AURO PHARMA INC | MARKETED | 02547023 |
| EDARBI | 40 MG | TABLET | BAUSCH HEALTH, CANADA INC. | MARKETED | 02381389 |
2 · Same class — other molecules in ATC C09CA
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Candesartan | ACCEL-CANDESARTAN · ACH-CANDESARTAN · ACT CANDESARTAN · AG-CANDESARTAN · AG-CANDESARTAN TABLETS · APO-CANDESARTAN · APO-CANDESARTAN TABLETS · ATACAND · AURO-CANDESARTAN · BIO-CANDESARTAN · CANDESARTAN · CANDESARTAN CILEXETIL · DOM-CANDESARTAN · IPG-CANDESARTAN · JAMP-CANDESARTAN · MINT-CANDESARTAN · MYLAN-CANDESARTAN · NRA-CANDESARTAN · NTP-CANDESARTAN · PMS-CANDESARTAN · PRIVA-CANDESARTAN · Q-CANDESARTAN · RIVA-CANDESARTAN · SANDOZ CANDESARTAN · SEPTA-CANDESARTAN · TARO-CANDESARTAN · TEVA-CANDESARTAN · ZINDA-CANDESARTAN | 126 | 51 | Yes |
| Irbesartan | ACT IRBESARTAN · AG-IRBESARTAN · APO-IRBESARTAN · AURO-IRBESARTAN · AVA-IRBESARTAN · AVAPRO · BIO-IRBESARTAN · DOM-IRBESARTAN · IPG-IRBESARTAN · IRBESARTAN · JAMP IRBESARTAN · JAMP-IRBESARTAN · M-IRBESARTAN · MAR-IRBESARTAN · MINT-IRBESARTAN · MYLAN-IRBESARTAN · NB-IRBESARTAN · NTP-IRBESARTAN · PENDO-IRBESARTAN · PMS-IRBESARTAN · PRIVA-IRBESARTAN · Q-IRBESARTAN · RIVA-IRBESARTAN · SANDOZ IRBESARTAN · TARO-IRBESARTAN · TEVA-IRBESARTAN · VAN-IRBESARTAN | 103 | 38 | Yes |
| Valsartan | ACT VALSARTAN · APO-VALSARTAN · AURO-VALSARTAN · AVA-VALSARTAN · DIOVAN · DIOVAN 160MG · DIOVAN 160MG TABLETS · DIOVAN 80MG · DIOVAN 80MG TABLETS · DOM-VALSARTAN · M-VALSARTAN · MYLAN-VALSARTAN · NOVO-VALSARTAN · PMS-VALSARTAN · Q-VALSARTAN · REDDY-VALSARTAN · RIVA-VALSARTAN · SANDOZ VALSARTAN · TARO-VALSARTAN · TEVA-VALSARTAN · VALSARTAN | 85 | 31 | Yes |
| Losartan | ACT LOSARTAN · AG-LOSARTAN · APO-LOSARTAN · AURO-LOSARTAN · BIO-LOSARTAN · COZAAR · DOM-LOSARTAN · IPG-LOSARTAN · JAMP-LOSARTAN · LOSARTAN · LOSARTAN POTASSIUM · MAR-LOSARTAN · MINT-LOSARTAN · MYLAN-LOSARTAN · PHL-LOSARTAN · PMS-LOSARTAN · PRIVA-LOSARTAN · SANDOZ LOSARTAN · SEPTA-LOSARTAN · TARO-LOSARTAN · TEVA-LOSARTAN · VAN-LOSARTAN | 81 | 27 | Yes |
| Telmisartan | ACH-TELMISARTAN · ACT TELMISARTAN · AG-TELMISARTAN · ALEMBIC-TELMISARTAN · APO-TELMISARTAN · AURO-TELMISARTAN · BIO-TELMISARTAN · JAMP TELMISARTAN · MAR-TELMISARTAN · MICARDIS 40MG TAB · MICARDIS 80MG TAB · MINT-TELMISARTAN · MYLAN-TELMISARTAN · NRA-TELMISARTAN · NTP-TELMISARTAN · PENDO-TELMISARTAN · PHARMA-TELMISARTAN · PMS-TELMISARTAN · RAN-TELMISARTAN · SANDOZ TELMISARTAN · SEPTA-TELMISARTAN · TELMISARTAN · TEVA-TELMISARTAN · VAN-TELMISARTAN | 52 | 26 | Yes |
| Olmesartan Medoxomil | ACH-OLMESARTAN · AG-OLMESARTAN · APO-OLMESARTAN · AURO-OLMESARTAN · GLN-OLMESARTAN · JAMP OLMESARTAN · M-OLMESARTAN · MED-OLMESARTAN · NRA-OLMESARTAN · OLMESARTAN · OLMETEC · PMS-OLMESARTAN · PRZ-OLMESARTAN · RIVA-OLMESARTAN · SANDOZ OLMESARTAN · TEVA-OLMESARTAN | 42 | 22 | Yes |
| Azilsartan Medoxomil | AURO-AZILSARTAN MEDOXOMIL · EDARBI | 4 | 4 | Yes |
| Eprosartan | TEVETEN · TEVETEN TABLETS 300 MG | 3 | 0 | Not in Canada |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.